Acadia Healthcare Company, Inc.
ACHC· Nasdaq
Released Jul 31, 2024, after the close
10-Q filed Aug 1, 2024, 32 days after period end · 0000950170-24-089248
| Metric | Q2 2024 | Q2 2023 | Q2 2022 | Q2 2021 |
|---|---|---|---|---|
| Revenue | $796.04M | $731.34M | $651.72M | $582.16M |
| Net Income | $78.48M | $72.30M | $80.08M | $44.51M |
| EPS Diluted |
Acadia Healthcare Company, Inc. · CIK 1520697 · Engraved from SEC EDGAR
| $0.85 |
| $0.79 |
| $0.88 |
| $0.49 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.